Impact of HER2 Overexpression and Coexpression of Hormonal Receptors on Pathological Response after Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

被引:0
|
作者
Moscoso, Louis [1 ]
Ruiz-Merino, Guadalupe
Huayna, Lourdes Salazar [1 ]
Iborra-Lacal, Emma
de Romani, Santiago Escriva [2 ]
Jimenez-Lucas, Maria
Raber, Christian Siso [1 ]
Cabezas-Herrera, Juan
Peg, Vicente [1 ]
Ramon Y Cajal, Santiago [3 ]
Pinero-Madrona, Antonio
机构
[1] Hosp Univ Vall dHebron, Barcelona, Spain
[2] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain
[3] Vall dHebron Univ Hosp, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
152
引用
收藏
页码:168 / 169
页数:2
相关论文
共 50 条
  • [1] Impact of HER2 Overexpression and Coexpression of Hormonal Receptors on Pathological Response after Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
    Moscoso, Louis
    Ruiz-Merino, Guadalupe
    Salazar Huayna, Lourdes
    Iborra-Lacal, Emma
    Escriva de Romani, Santiago
    Jimenez-Lucas, Maria
    Siso Raber, Christian
    Cabezas-Herrera, Juan
    Peg, Vicente
    Ramon Y Cajal, Santiago
    Pinero-Madrona, Antonio
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 168 - 169
  • [2] Immunohistochemical HER2 score correlates with response to neoadjuvant chemotherapy in HER2-positive primary breast cancer
    Yihong Wang
    Kamaljeet Singh
    Don Dizon
    Teresa Graves
    Ali Amin
    Evgeny Yakirevich
    Breast Cancer Research and Treatment, 2021, 186 : 667 - 676
  • [3] Immunohistochemical HER2 score correlates with response to neoadjuvant chemotherapy in HER2-positive primary breast cancer
    Wang, Yihong
    Singh, Kamaljeet
    Dizon, Don
    Graves, Teresa
    Amin, Ali
    Yakirevich, Evgeny
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (03) : 667 - 676
  • [4] Prognostic implications of HER2 change after neoadjuvant chemotherapy in HER2-positive breast cancer patients
    Sato, A.
    Maeda, Y.
    Matsumoto, A.
    Ikeda, T.
    Jinno, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1409 - S1409
  • [5] Loss of HER2 expression in HER2-positive breast cancer patients after neoadjuvant therapy
    Sang, Yuting
    Wu, Jiong
    Yang, Benlong
    CANCER RESEARCH, 2022, 82 (04)
  • [6] Alterations in HER2 status and outcome following neoadjuvant chemotherapy in HER2-positive breast cancer (BC)
    Ng, Dianna
    Krings, Gregor
    Yau, Christina
    White, Kristie
    Hou, Jie
    Chua, Anthony
    Grenert, James P.
    Chen, Yunn-Yi
    CANCER RESEARCH, 2015, 75
  • [7] Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
    Horimoto, Yoshiya
    Ishizuka, Yumiko
    Ueki, Yuko
    Higuchi, Toru
    Arakawa, Atsushi
    Saito, Mitsue
    BMC CANCER, 2022, 22 (01)
  • [8] Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
    Yoshiya Horimoto
    Yumiko Ishizuka
    Yuko Ueki
    Toru Higuchi
    Atsushi Arakawa
    Mitsue Saito
    BMC Cancer, 22
  • [9] Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer
    Katayama, Ayaka
    Miligy, Islam M.
    Shiino, Sho
    Toss, Michael S.
    Eldib, Karim
    Kurozumi, Sasagu
    Quinn, Cecily M.
    Badr, Nahla
    Murray, Ciara
    Provenzano, Elena
    Callagy, Grace
    Martyn, Cian
    Millican-Slater, Rebecca
    Purdie, Colin
    Purnell, Dave
    Pinder, Sarah E.
    Oyama, Tetsunari
    Shaaban, Abeer M.
    Ellis, Ian
    Lee, Andrew H. S.
    Rakha, Emad A.
    MODERN PATHOLOGY, 2021, 34 (07) : 1271 - 1281
  • [10] Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?
    Antolin, Silvia
    Garcia-Caballero, Lucia
    Reboredo, Cristina
    Molina, Aurea
    Mosquera, Joaquin
    Vazquez-Boquete, Angel
    Gallego, Rosalia
    Santiago, Mari Paz
    Concha, Angel
    Perez, Eva
    Calvo, Lourdes
    Garcia-Caballero, Tomas
    VIRCHOWS ARCHIV, 2021, 479 (04) : 853 - 857